Mycoses

Papers
(The TQCC of Mycoses is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia201
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis157
Physicians' knowledge of invasive fungal disease in China129
Author Index110
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country83
82
State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)53
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist47
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China46
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis44
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia43
Emergence of Candida auris in intensive care units in Algeria40
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis38
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil38
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease37
Review Article White Piedra: Review of 131 cases37
Issue Information37
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat37
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis33
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant32
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis31
Issue Information30
Changing demographics and risk factors for cryptococcosis: A 12‐year review at a tertiary care centre30
Issue Information29
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg1129
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study26
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture26
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years26
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training26
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review26
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates25
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”25
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil25
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic25
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis24
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil24
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole24
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment23
Cover Image23
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies22
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection22
Tinea pedis in underrepresented groups: All of Us database analysis21
Issue Information21
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I21
Diagnostic performance of noncultural methods for central nervous system aspergillosis20
CARD9 mutations in patients with fungal infections: An update from the last 5 years20
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐centre experience in Iran20
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis20
Performance of the RealStar®Pneumocystis jirovecii PCR kit for the diagnosis of Pneumocystis pneumonia20
20
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients20
19
How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?19
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases18
18
18
Expression of epidermal antimicrobial peptides is increased in tinea pedis18
Fungaemia due to rare yeasts in paediatric intensive care units: A prospective study17
17
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia17
Immune reconstitution inflammatory syndrome in non‐HIV cryptococcal meningitis: Cross‐talk between pathogen and host17
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato17
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda16
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases16
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice16
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence 16
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study16
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease16
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis15
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–202015
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)15
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor15
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade15
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries15
Issue Information14
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire14
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors14
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients14
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain14
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores14
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study14
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata14
14
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India14
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections13
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment13
13
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 1713
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes13
12
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study12
12
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida12
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature12
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study12
Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis—A Six‐year Retrospective Cohort Study12
Morphological and genetic identification of fungal genus/species in formalin‐fixed, paraffin‐embedded specimens obtained from patients with histologically proven fungal infection12
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections12
Issue Information11
Posters11
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections11
11
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures11
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response11
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?11
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans10
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis10
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres10
Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case‐control study10
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit10
Expert recommendations for prevention and management of Candida auris transmission10
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients10
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis10
Aspergillus nodules: Natural history and the effect of antifungals10
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study10
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?10
10
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic9
Coccidioidomycosis in Oklahoma: A retrospective case series9
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases9
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases9
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting9
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States9
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTERIFI study9
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 20239
Updated estimation of the burden of fungal disease in Vietnam9
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital9
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients9
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis9
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)9
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France 9
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management9
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study9
Abstracts8
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases8
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro8
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador8
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus8
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality8
Issue Information8
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation8
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases8
Serious fungal disease incidence and prevalence in Indonesia8
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 20218
Paediatric cutaneous mucormycosis: A case report and review of the literature8
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes8
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris8
Time and cost‐efficient identification of Trichophyton indotineae8
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance8
Issue Information7
7
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance7
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital7
An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma7
Altered skin fungal and bacterial community compositions in tinea capitis7
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis7
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum7
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database7
Molecular genotyping of Candidaalbicans isolated from different sites may trace the etiological infection routes: Observation in China7
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies7
A simple high‐volume culture technique—Good substitute for polymerase chain reaction for the detection of Aspergillus species in bronchoalveolar lavage samples7
Anti‐fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta‐analysis7
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment7
Issue Information7
Invasive fungal infections in acute and chronic liver impairment: A systematic review7
7
0.12074708938599